Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of microRNAs in arrhythmogenic cardiomyopathy: translation as biomarkers into clinical practice.

Translational research : the journal of laboratory and clinical medicine - 1 Sept 2023

Alcalde Mireia, Toro Rocío, Bonet Fernando, Córdoba-Caballero José, Martínez-Barrios Estefanía, Ranea Juan Antonio, Vallverdú-Prats Marta, Brugada Ramon, Meraviglia Viviana, Bellin Milena, Sarquella-Brugada Georgia, Campuzano Oscar

Abstract excerpt

Arrhythmogenic cardiomyopathy is a rare inherited entity, characterized by a progressive fibro-fatty replacement of the myocardium. It leads to malignant arrhythmias and a high risk of sudden cardiac death. Incomplete penetrance and variable expressivity are hallmarks of this arrhythmogenic cardiac disease, where the first manifestation may be syncope and sudden cardiac death, often triggered by physical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arrhythmogenic Right Ventricular Dysplasia
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Death, Sudden, Cardiac

Share to Genetic Predisposition to Disease

Share to MicroRNAs

Source

Identifiers

PMID: 37105319
DOI: 10.1016/j.trsl.2023.04.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of microRNAs in arrhythmogenic cardiomyopathy: translation as biomarkers into clinical practice.PMID 37105319Read ↗

The Role of MicroRNAs in Arrhythmogenic Cardiomyopathy: Biomarkers or Innocent Bystanders of Disease Progression?Semantic proximity Read ↗

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated CardiomyopathySemantic proximity Read ↗

A microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy CohortSemantic proximity Read ↗

The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old EntitySemantic proximity Read ↗

MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkersSemantic proximity Read ↗

Cardiomyopathies: The Role of Non-Coding RNAsSemantic proximity Read ↗

New Insights into the Functions of MicroRNAs in Cardiac Fibrosis: From Mechanisms to Therapeutic StrategiesSemantic proximity Read ↗

Long noncoding RNAs and microRNAs in cardiovascular pathophysiology.Semantic proximity Read ↗

A novel murine model for arrhythmogenic cardiomyopathy points to a pathogenic role of Wnt signalling and miRNA dysregulationSemantic proximity Read ↗

Role of microRNAs in cardiac remodelling: New insights and future perspectivesSemantic proximity Read ↗

Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy.Semantic proximity Read ↗

MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.